Psilocybin use in Psychiatric Disorders

Room Parasol I


Speaker(s): 

Ali Mahmoud, MD

Description: 

Recent researches have proven that psilocybin has a wide rage of therapeutic benefits especially in Treatment- Resistant depression. FDA has recently gave psilocybin a ” breakthrough therapy designation” for treatment-resistant depression. In my presentation will talk in detail about psilocybin pharmacology, pharmacokinetics and will give overview on its therapeutic benefits based on recents studies.

Objectives

  • Obtain knowledge on history of psychedelic therapy from the past to the present time
  • Define psilocybin pharmacology
  • Discuss therapeutic benefits of psilocybin especially in treatment resistant depression
  • Discuss “assistant therapy ” and its phases

Mahmoud, Ali, MD

I am a PGY-4 psychiatry resident at University of Missouri- Columbia program. I obtained my Bachelor degree in Medicine and Surgery from University of Alexandria in Egypt. I did my neuropsychiatry residency training in Alexandria /Egypt from 2005-2008. I also did another 5-year psychiatry residency training in Kuwait ( 2014-2019). I will be talking about Psilocybin use in psychiatric disorders. I did my grand round on this topic last year. You can access this presentation here : https://www.youtube.com/watch?v=iYvADrq9zHw.
Presentation(s):

Beck, Niels, PhD

Niels C Beck received his PhD in Clinical Psychology from St. Louis University. Currently, he works as a consultant to the State Hospital in Fulton and assists with a variety of applied research and quality improvement projects. Previously, he was a tenured full professor at the University of Missouri Medical School, where he served as vice-chair of the Department of Psychiatry. Dr. Beck and his colleagues at Fulton have done work related to inpatient aggression since the early 1990s.
Presentation(s):

Choate, Alexandria, MA

Allie Choate is a doctoral candidate in clinical psychology at the University of South Florida. She is currently completing her pre-doctoral internship at Fulton State Hospital. Her research focuses on understanding developmental mechanisms that foster the development of borderline personality disorder (BPD) traits, as well as their co-occurrence with other forms of psychopathology and problematic behavior, such as substance use and aggression.
 

Presentation(s):